Published in
Impact Journals, Oncotarget, 51(7), p. 85306-85317, 2016
DOI: 10.18632/oncotarget.13301
Links
Tools
Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group
Journal article published in 2016 by
Stéphane Oudard 
,
Reza Elaidi,
Mara Brizard,
Céline Le Rest,
Céline Le Rest,
Valérie Caillet,
Sophie Deveaux,
Gérard Benoit,
Jean-Michel Corréas,
Farida Benoudiba,
Philippe David,
Alain Gaudric,
Pascal Hammel,
Dominique Joly,
Marc Olivier Timsit
and other authors.
,
Reza Elaidi,
Mara Brizard,
Céline Le Rest,
Céline Le Rest,
Valérie Caillet,
Sophie Deveaux,
Gérard Benoit,
Jean-Michel Corréas,
Farida Benoudiba,
Philippe David,
Alain Gaudric,
Pascal Hammel,
Dominique Joly,
Marc Olivier Timsit
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 